News

kriya-news-banner

May 16, 2022

Kriya Announces $270 Million Series C Financing to Advance Fully Integrated Gene Therapy Engine

: Kriya Announces $270 Million Series C Financing to Advance Fully Integrated Gene Therapy Engine
January 26, 2022

Kriya Licenses Next Generation Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases

: Kriya Licenses Next Generation Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases
July 28, 2021

Kriya Therapeutics Completes Renovation of its Facility for Scalable Gene Therapy Manufacturing

: Kriya Therapeutics Completes Renovation of its Facility for Scalable Gene Therapy Manufacturing
July 14, 2021

Kriya Therapeutics Completes $100 Million Series B Financing to Advance its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies

: Kriya Therapeutics Completes $100 Million Series B Financing to Advance its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies
August 4, 2020

Kriya Therapeutics Announces the Establishment of its Internal Manufacturing Facility for Process Development and Scalable cGMP Production of Gene Therapies for Prevalent Serious Diseases

: Kriya Therapeutics Announces the Establishment of its Internal Manufacturing Facility for Process Development and Scalable cGMP Production of Gene Therapies for Prevalent Serious Diseases
May 12, 2020

Kriya Therapeutics Announces $80 Million Series A Financing to Advance Gene Therapies for Highly Prevalent Serious Diseases

: Kriya Therapeutics Announces $80 Million Series A Financing to Advance Gene Therapies for Highly Prevalent Serious Diseases